0001104659-23-082196.txt : 20230719 0001104659-23-082196.hdr.sgml : 20230719 20230719080635 ACCESSION NUMBER: 0001104659-23-082196 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230718 FILED AS OF DATE: 20230719 DATE AS OF CHANGE: 20230719 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mosseri Marlio Charles CENTRAL INDEX KEY: 0001806384 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41264 FILM NUMBER: 231095609 MAIL ADDRESS: STREET 1: 27 RIPPLEVALE GROVE CITY: LONDON STATE: X0 ZIP: N1 1HS ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nuvectis Pharma, Inc. CENTRAL INDEX KEY: 0001875558 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 862405608 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 BRIDGE PLAZA, SUITE 275 CITY: FORT LEE STATE: NJ ZIP: 07024 BUSINESS PHONE: 360-837-7232 MAIL ADDRESS: STREET 1: 1 BRIDGE PLAZA, SUITE 275 CITY: FORT LEE STATE: NJ ZIP: 07024 4 1 tm2321610d1_4seq1.xml 4 X0508 4 2023-07-18 0 0001875558 Nuvectis Pharma, Inc. NVCT 0001806384 Mosseri Marlio Charles 27 RIPPLEVALE GROVE LONDON N1 1HS LIBYAN ARAB JAMAHIRIYA 0 0 1 0 0 Common Stock 2023-07-18 4 P 0 9149 14.84 A 2563762 D Reflects the weighted average purchase price. The range of prices for the shares purchased was $14.71 to $14.94. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. /s/ Charles Mosseri-Marlio 2023-07-19